Healthcare Marketing Blogs
11|04|25
Dreamforce 2025: What Pharma Should Really Take Away
If you blinked during Dreamforce this year, you might have missed that Salesforce quietly signaled a major shift in how enterprises, including life sciences organizations, will operate in the years ahead. Let’s unpack what that transformation looks like and why it matters for pharma, especially for teams navigating compliance, content and complexity every single day.
11|03|25
Creativity Within Constraints: Pharma’s New Frontier
In a world where regulatory scrutiny often feels like a creative straitjacket, Susan Perlbachs, Chief Creative Officer, offers a refreshing counterpoint: breakthrough is not only possible—it’s happening. In her latest feature for MM+M, Susan spotlights four pharma ads that defy expectations and prove that artistry and compliance can coexist.
10|23|25
Cannes Lions 2025: EVERSANA INTOUCH Celebrated in the Top 5 for Global Creativity
EVERSANA INTOUCH has been named a Top 5 Healthcare Agency in the Cannes Lions 2025 Creativity Ranking Report — a global benchmark celebrating the boldest, most brilliant work shaping culture, driving business, and redefining creativity.
10|22|25
Pharma’s Next Wave: Precision, Trust and Transformation Insights from DHC Disrupt Summit
At this year’s Digital Healthcare Coalition (DHC) Disrupt Summit, pharma’s most forward-thinking marketers explored how technology and innovation are reshaping engagement across the healthcare ecosystem. Faruk Capan, CEO of EVERSANA INTOUCH and Chief Innovation Officer at EVERSANA, joined industry peers, Corrine Lynberg (Novo Nordisk), Eric McCulley (UCB Pharma), and Mark Bard, Co-Founder of The DHC […]
10|07|25
Looking Ahead to Dreamforce 2025
Every year, Dreamforce brings together leaders, innovators, and partners across industries to explore the future of Salesforce technology. This year feels especially pivotal for the Life Sciences sector, as new technologies and strategies are reshaping how pharma and biotech organizations work, connect, and deliver impact. Our team is proud to represent EVERSANA INTOUCH at Dreamforce […]
10|02|25
Unpacking the FDA’s Double Standard
In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.
09|25|25
Navigating the FDA’s DTC Crackdown: What Pharma Marketers Need to Know
The FDA’s recent wave of warning letters targeting direct-to-consumer (DTC) pharmaceutical advertising has sent ripples through the industry. While the agency’s actions may not make TV advertising impossible, they do signal a significant tightening of enforcement—particularly around the Clear, Conspicuous, and Neutral (CCN) standard. Read the blog to learn more.
09|24|25
Finding the Unfindable: The Artful Ingenuity of AI-Powered Patient Finding
Millions of patients remain undiagnosed or unaware of effective treatments — delaying care and leaving brands with untapped opportunity. Traditional approaches often fall short, but AI-powered patient-finding is changing the game. Our latest POV explores how a strategic combination of diverse data, cross-disciplinary clinical expertise, and advanced AI tools — what we call Artful Ingenuity […]
09|03|25
Evolving Search Engine Marketing in Pharma: A New Era of Targeting Capabilities
A Google update marks a major shift for pharma marketers, enabling the use of first-party data tools like Customer Match and Remarketing, capabilities previously restricted in sensitive categories. These changes open new doors for precision targeting of HCPs and improved ROI in paid search. Download the POV to learn how your brand can stay competitive in this evolving landscape.
08|28|25
Marketing in the Age of Uncertainty: Preparing for a Post-DTC World
As proposed legislation threatens to ban direct-to-consumer (DTC) pharmaceutical advertising, our experts offer a timely perspective on how pharma marketers can navigate this evolving landscape. In an era defined by regulatory uncertainty and shifting patient expectations, this POV outlines actionable strategies to stay compliant, connected and competitive. Download the POV to discover how marketers can lead the next chapter of healthcare engagement with agility and purpose.